| P2093 | author name string | Hitoshi Tanimukai | |
| | Yoichi Matsuda | |
| | Yoshiaki Okamoto | |
| | Etsuko Uejima | |
| | Mamiko Tsugane | |
| | Yumiko Ohno | |
| | Satoru Tsuneto | |
| P2860 | cites work | Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study | Q31454905 |
| | Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes | Q33723068 |
| | Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients | Q33899569 |
| | Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain | Q35041376 |
| | Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review | Q35844625 |
| | The role of ketamine in pain management. | Q36541128 |
| | Ketamine for chronic non-cancer pain | Q37364252 |
| | NMDA receptor antagonists for the treatment of neuropathic pain | Q37806320 |
| | Morphine with adjuvant ketamine vs higher dose of morphine alone for immediate postthoracotomy analgesia | Q38387603 |
| | Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. | Q39300898 |
| | A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trial. | Q39406336 |
| | "Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients | Q39414184 |
| | Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain | Q39440047 |
| | Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia | Q39475248 |
| | Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient | Q44333045 |
| | The synergistic effect of combined treatment with systemic ketamine and morphine on experimentally induced windup-like pain in humans | Q44904492 |
| | Subanesthetic ketamine: an essential adjuvant for intractable cancer pain. | Q44994476 |
| | Successful use of ketamine for intractable cancer pain | Q45103999 |
| | Ketamine spares morphine consumption after transthoracic lung and heart surgery without adverse hemodynamic effects | Q46501023 |
| | Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report. | Q51447315 |
| P433 | issue | 5 | |
| P921 | main subject | pain management | Q621261 |
| | neuropathic pain | Q2798704 |
| P304 | page(s) | 450-454 | |
| P577 | publication date | 2012-07-24 | |
| P1433 | published in | American Journal of Hospice and Palliative Medicine | Q4744247 |
| P1476 | title | Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer? | |
| P478 | volume | 30 | |